Family summary
Current and historical shortage references are available across related Cefazolin presentations from multiple manufacturers.
- 4 current shortage context pages.
- 12 historical shortage context pages.
- 5 manufacturers represented.
Cefazolin - Drug Shortage Information
Public shortage context is available across 16 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
Cefazolin 3 g / 1 Injection 25 Vial, Single-Dose - NDC 60505-6266-05Apotex Corp. | 25 Vial, Single-DoseCefazolin 3 g / 1 Injection 25 Vial - NDC 00143-9140-25Hikma Pharmaceuticals USA Inc. | 25 VialCefazolin 225 mg / mL Injection 2.2 mL - NDC 00143-9923-90Hikma Pharmaceuticals USA Inc. | 2.2 mLCefazolin 1 g / 1 Injection 25 Vial - NDC 00409-2585-01Hospira, Inc | 25 VialCefazolin 1 g / 1 Injection 25 Vial, Single-Dose - NDC 60505-6142-05Apotex Corp. | 25 Vial, Single-Dose
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.